X-100914774-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_212559.3(XKRX):c.914G>A(p.Arg305Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000118 in 1,209,668 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 47 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_212559.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
XKRX | NM_212559.3 | c.914G>A | p.Arg305Gln | missense_variant | Exon 3 of 3 | ENST00000372956.3 | NP_997724.2 | |
XKRX | XM_011530954.4 | c.953G>A | p.Arg318Gln | missense_variant | Exon 3 of 4 | XP_011529256.1 | ||
XKRX | XM_011530955.2 | c.566G>A | p.Arg189Gln | missense_variant | Exon 4 of 4 | XP_011529257.1 | ||
XKRX | XM_017029517.2 | c.302G>A | p.Arg101Gln | missense_variant | Exon 2 of 2 | XP_016885006.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000144 AC: 16AN: 111388Hom.: 0 Cov.: 23 AF XY: 0.0000893 AC XY: 3AN XY: 33586
GnomAD3 exomes AF: 0.000262 AC: 48AN: 183372Hom.: 0 AF XY: 0.000192 AC XY: 13AN XY: 67840
GnomAD4 exome AF: 0.000116 AC: 127AN: 1098227Hom.: 0 Cov.: 31 AF XY: 0.000121 AC XY: 44AN XY: 363581
GnomAD4 genome AF: 0.000144 AC: 16AN: 111441Hom.: 0 Cov.: 23 AF XY: 0.0000892 AC XY: 3AN XY: 33649
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.914G>A (p.R305Q) alteration is located in exon 3 (coding exon 3) of the XKRX gene. This alteration results from a G to A substitution at nucleotide position 914, causing the arginine (R) at amino acid position 305 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at